Ischemic attack treatment
Pro Research Analysisby 
Searched over 200M research papers
Advances in Ischemic Attack Treatment
Reperfusion Therapy for Acute Ischemic Stroke
Intravenous Thrombolysis and Mechanical Thrombectomy
Reperfusion therapy remains the cornerstone of acute ischemic stroke treatment. Intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (rtPA) is effective when administered within 4.5 hours of symptom onset. Mechanical thrombectomy, an endovascular therapy, is recommended for patients with large artery occlusion and can be performed within 6 hours of symptom onset Rabinstein2020Catanese2017. Recent studies have expanded the time window for mechanical thrombectomy up to 24 hours in selected patients, such as those with wake-up strokes, using advanced imaging techniques to identify candidates .
Imaging Techniques for Patient Selection
Timely imaging, including computed tomography (CT) and magnetic resonance imaging (MRI), is crucial for selecting patients for both IV thrombolysis and intra-arterial (IA) therapy. These imaging modalities help identify large-vessel occlusions and assess the ischemic core and penumbra, which are critical for determining the therapeutic window and potential benefit from reperfusion therapy .
Antiplatelet Therapy for Secondary Prevention
Common Antiplatelet Agents
Antiplatelet therapy is essential for the secondary prevention of ischemic stroke and transient ischemic attack (TIA). Commonly used antiplatelet agents include aspirin, aspirin-dipyridamole, clopidogrel, and ticagrelor. These agents have been extensively studied and are recommended in practice guidelines to reduce the risk of recurrent vascular events .
Efficacy and Usage
Aspirin is often preferred due to its favorable results in preventing TIA and stroke, especially in patients where hypertension, compliance, and laboratory monitoring are concerns . Clopidogrel and aspirin-dipyridamole are also effective alternatives, with specific indications based on patient profiles and risk factors .
Novel Therapeutic Approaches
Neuroprotective Strategies
Neuroprotective strategies aim to preserve the salvageable penumbra and improve long-term outcomes. However, delivering neuroprotective drugs effectively to the ischemic brain remains challenging. Recent research has focused on novel drug delivery systems to enhance the efficacy of these treatments .
Polyphenolic Compounds
Polyphenolic compounds have shown promise in animal models due to their ability to target multiple ischemic pathways. Despite their potential, low bioavailability limits their clinical application. Strategies to improve bioavailability are under investigation to make these compounds viable therapeutic options .
Stem Cell Therapy
Stem cell therapy is emerging as a potential treatment for ischemic stroke, offering mechanisms such as cell differentiation, replacement, and immunomodulation. Various stem cell types, including mesenchymal and neural stem cells, have been explored. Biomaterials are being developed to enhance stem cell survival and efficacy in the ischemic environment Zhou2021Jiang2022.
Conclusion
The treatment of ischemic stroke has significantly advanced with the development of reperfusion therapies, antiplatelet agents, and novel approaches like neuroprotective strategies and stem cell therapy. Timely intervention and patient selection using advanced imaging are critical for optimizing outcomes. Continued research into drug delivery systems, polyphenolic compounds, and stem cell therapies holds promise for further improving the management of ischemic stroke.
Sources and full results
Most relevant research papers on this topic